E. Baumelou

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment [published erratum appears in Br J Rheumatol 1998 Oct;37(10):1142]

C J Hawkey, André Kahan, Klaus Steinbrück et al. · Lara D. Veeken · 1998 · 262 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX- inhibiting Therapies (SELECT) trial in osteoarthritis

J. Dequeker, Christopher J. Hawkey, André Kahan et al. · Lara D. Veeken · 1998 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Cyclosporin A as a modifier agent in the salvage treatment of acute leukemia (AL).

Jean Pierre Marie, Jean Bastié, Fabrice Coloma et al. · PubMed · 1993 · 54 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

Roel Willemze, Nico van der Lely, H. Zwierzina et al. · Annals of Hematology · 1992 · 44 citations

Medicine, Hematology, Immunology +15

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

R. Willemze, Nico van der Lely, H. Zwierzina et al. · Annals of Hematology · 1992 · 39 citations · Full text

Medicine, Hematology, Immunology +15